A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

Investing in biotech stocks can be risky, particularly in the clinical stage, since their success often hinges on the results ...

The annual BioVenture Partnership Event connects researchers with companies and investors to make their ideas a reality.

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

The nonprofit Bioversity is now part of the Lowell Innovation Network Corridor project, UMass Lowell's $800 million ...

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

It’s an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapeutics all going public with ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today ...

Bhubaneswar: The Biotechnology sector is poised to boost the Indian economy. Odisha with its rich biodiversity & vast ...